New Horizons in Microbiota and Metabolic Health Research

被引:5
|
作者
Mishra, Sidharth P. [1 ,2 ]
Jain, Shalini [3 ,4 ]
Taraphder, Subhash [2 ]
Yadav, Hariom [1 ]
机构
[1] Wake Forest Sch Med, Dept Internal Med Mol Med, Winston Salem, NC 27101 USA
[2] West Bengal Univ Anim & Fishery Sci, Dept Anim Genet & Breeding, Kolkata 700037, W Bengal, India
[3] Wake Forest Sch Med, Metab Phenotyping Shared Resource, Winston Salem, NC 27101 USA
[4] Wake Forest Sch Med, Dept Internal Med Endocrinol, Winston Salem, NC 27101 USA
基金
美国国家卫生研究院;
关键词
microbiota; gut; metabolic; diabetes; obesity; inflammation; brain; GUT MICROBIOTA; HYPOTHALAMUS; INFLAMMATION; EXPRESSION; METFORMIN; AXIS;
D O I
10.1210/clinem/dgaa769
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Decade-old studies have demonstrated that microbes living in our gut (microbiota) contribute to both maintaining normal metabolic function and to the pathology of metabolic diseases, such as obesity and diabetes. Emerging evidence suggests that gut microbiota influences the personalized effects of diets and drugs and impact the gut-brain axis and leaky gut inflammation to control metabolic function/diseases. Gut microbiota can be an ideal source of prognostic markers and therapies for metabolic diseases. Here we discuss the emerging concepts in the area of microbiota and metabolic interactions in personalized nutrition, drug response, and disease prognosis.
引用
收藏
页码:E1052 / E1059
页数:8
相关论文
共 50 条
  • [31] RETRACTED: Translational research into gut microbiota: new horizons in obesity treatment (Retracted Article)
    Tsukumo, Daniela M.
    Carvalho, Bruno M.
    Carvalho-Filho, Marco A.
    Saad, Mario J. A.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2009, 53 (02) : 139 - 144
  • [32] Diet as Regulator of Gut Microbiota and its Role in Health and Disease
    Sanchez-Tapia, Monica
    Tovar, Armando R.
    Torres, Nimbe
    ARCHIVES OF MEDICAL RESEARCH, 2019, 50 (05) : 259 - 268
  • [33] Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma
    Mathieu, Elliot
    Escribano-Vazquez, Unai
    Descamps, Delphyne
    Cherbuy, Claire
    Langella, Philippe
    Riffault, Sabine
    Remot, Aude
    Thomas, Muriel
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [34] Microbiota and metabolic diseases
    Pascale, Alessia
    Marchesi, Nicoletta
    Marelli, Cristina
    Coppola, Adriana
    Luzi, Livio
    Govoni, Stefano
    Giustina, Andrea
    Gazzaruso, Carmine
    ENDOCRINE, 2018, 61 (03) : 357 - 371
  • [35] Microbiota and metabolic diseases
    Alessia Pascale
    Nicoletta Marchesi
    Cristina Marelli
    Adriana Coppola
    Livio Luzi
    Stefano Govoni
    Andrea Giustina
    Carmine Gazzaruso
    Endocrine, 2018, 61 : 357 - 371
  • [36] Broadening horizons: intestinal microbiota as a novel biomarker and potential treatment for hypertensive disorders of pregnancy
    Wang, Min
    Zheng, Lianwen
    Meng, Yang
    Ma, Shuai
    Zhao, Donghai
    Xu, Ying
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [37] Gut Microbiota and Bone Health
    Quach, Darin
    Britton, Robert A.
    UNDERSTANDING THE GUT-BONE SIGNALING AXIS: MECHANISMS AND THERAPEUTIC IMPLICATIONS, 2017, 1033 : 47 - 58
  • [38] Microbiota Metabolites in Health and Disease
    McCarville, Justin L.
    Chen, Grischa Y.
    Cuevas, Victor D.
    Troha, Katia
    Ayres, Janelle S.
    ANNUAL REVIEW OF IMMUNOLOGY, VOL 38, 2020, 38 : 147 - 170
  • [39] The gut microbiota: A new target in the management of alcohol dependence?
    Leclercq, Sophie
    Starkel, Peter
    Delzenne, Nathalie M.
    de Timary, Philippe
    ALCOHOL, 2019, 74 : 105 - 111
  • [40] New dawn of ginsenosides: regulating gut microbiota to treat metabolic syndrome
    Bai, Xue
    Fu, Rongzhan
    Deng, Jianjun
    Yang, Haixia
    Zhu, Chenhui
    Fan, Daidi
    PHYTOCHEMISTRY REVIEWS, 2024, 23 (04) : 1247 - 1269